Clinical Research During a Public Health Emergency: A Systematic Review of Severe Pandemic Influenza Management*

Objective:Rigorous evaluation of clinical interventions in the setting of a public health emergency is necessary to identify best practices, to develop clinical management guidelines, and to inform resource allocation. The 2009 influenza A (H1N1) pandemic necessitated care of critically ill patients around the world. To inform the World Health Organization Public Health Research Agenda for Influenza, we conducted a systematic review to identify clinical interventions other than antiviral therapies that would benefit severely ill 2009 H1N1 influenza patients (adults and children) in both high- and low-resource settings. Data Sources:PubMed, EMBASE, Cochrane Central Register of Clinical Trials, and Cochrane Database of Systematic Reviews; hand search of abstracts from six professional society annual conferences and bibliographies of clinical review articles; and personal communication with leaders in the field. Study Selection:English language; human studies; citations added to databases from January 1, 2009 (Cochrane databases) or March 15, 2009 (PubMed and EMBASE) through January 31, 2012; randomized controlled trials, prospective cohort studies, or systematic reviews/meta-analyses of non-antiviral clinical interventions in hospitalized 2009 influenza A (H1N1) patients. Data Extraction:The search identified 2,452 articles. Thirty-six potentially relevant articles were read. Seven articles met criteria. All were observational studies. Data Synthesis:One study found benefit of convalescent plasma infusion, three studies found no benefit of corticosteroids, and three studies had mixed results on the benefit of extracorporeal lung support. No study was applicable to health care delivery in low-resource settings. Conclusions:There is a paucity of high quality clinical research to inform clinical care of severe H1N1 influenza, and we found no beneficial interventions appropriate for low-resource settings. This may be due to the logistical difficulties of conducting clinical research in response to a public health emergency. Our investigation underscores the need for the development of outbreak-ready research capacity in both high- and low-resource settings.

[1]  J. Masse.  Strengthening the reporting of observational studies in epidemiology-molecular epidemiology (STROBE-ME): an extension of the STROBE statement. , 2013, Journal of clinical epidemiology.

[2]  R. Balk.  A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic , 2011 .

[3]  R. Charrel,et al.  Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study , 2010, Intensive Care Medicine.

[4]  E. Ruokonen,et al.  Corticosteroid therapy in intensive care unit patients with PCR‐confirmed influenza A(H1N1) infection in Finland , 2011, Acta anaesthesiologica Scandinavica.

[5]  C. Sprung,et al.  Early observational research and registries during the 2009–2010 influenza A pandemic , 2010, Critical care medicine.

[6]  J. Chiche,et al.  Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection , 2010, Intensive Care Medicine.

[7]  J. Ioannidis,et al.  Corrigendum to "STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement" (Prev. Med. 53 (2011) 377-387) , 2012 .

[8]  Kwok-Hung Chan,et al.  Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Margaret E Kruk,et al.  Access to emergency and surgical care in sub-Saharan Africa: the infrastructure gap. , 2012, Health policy and planning.

[10]  D. Annane,et al.  InFACT: a global critical care research response to H1N1 , 2010, The Lancet.

[11]  M. Callaghan,et al.  Epidemiology, clinical characteristics and resource implications of pandemic (H1N1) 2009 in intensive care units in Ireland. , 2010, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[12]  J. Ndihokubwayo,et al.  Emerging Problems in Infectious Diseases Influenza preparedness in low-resource settings: a look at oxygen delivery in 12 African countries , 2010 .

[13]  S. Lapinsky.  Epidemic viral pneumonia , 2010, Current opinion in infectious diseases.

[14]  E. Riviello,et al.  Critical care in resource-poor settings: Lessons learned and future directions* , 2011, Critical care medicine.

[15]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[16]  R. Bellomo,et al.  Critical care services and 2009 H1N1 influenza in Australia and New Zealand. , 2009, The New England journal of medicine.

[17]  Kamolrat Silamut,et al.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial , 2010, The Lancet.

[18]  Anand Kumar,et al.  Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada , 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[19]  Susanna Price,et al.  Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). , 2011, JAMA.

[20]  J. Moran,et al.  Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis , 2008, BMJ : British Medical Journal.

[21]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[22]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.

[23]  K. Maitland,et al.  Mortality after fluid bolus in African children with severe infection. , 2011, The New England journal of medicine.

[24]  N. Kissoon,et al.  Recommendations for sepsis management in resource-limited settings , 2012, Intensive Care Medicine.

[25]  T. West,et al.  Strategies to Reduce Mortality from Bacterial Sepsis in Adults in Developing Countries , 2008, PLoS medicine.

[26]  J. Craig,et al.  Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis* , 2009, Critical care medicine.

[27]  Md. Mizanur Rahman,et al.  Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial , 2009, The Lancet.

[28]  P. Horby,et al.  Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.

[29]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[30]  G. Rubenfeld,et al.  Critical care and the global burden of critical illness in adults , 2010, The Lancet.

[31]  L. Brochard,et al.  Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic , 2012, Critical Care.

[32]  L. Brochard,et al.  Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. , 2011, American journal of respiratory and critical care medicine.